Sphingosine 1-phosphate pathway therapeutics: a lipid ligand–receptor paradigm
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 7 (4) , 461-468
- https://doi.org/10.1016/s1367-5931(03)00085-1
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Sphingosine-1-phosphate: an enigmatic signalling lipidNature Reviews Molecular Cell Biology, 2003
- Inhibitory and Stimulatory Regulation of Rac and Cell Motility by the G12/13-Rho and Gi Pathways Integrated Downstream of a Single G Protein-Coupled Sphingosine-1-Phosphate Receptor IsoformMolecular and Cellular Biology, 2003
- Marked Perinatal Lethality and Cellular Signaling Deficits in Mice Null for the Two Sphingosine 1-Phosphate (S1P) Receptors, S1P2/LPB2/EDG-5 and S1P3/LPB3/EDG-3Published by Elsevier ,2002
- The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate ReceptorsJournal of Biological Chemistry, 2002
- Activation of caspases and mitochondria in FTY720-mediated apoptosis in human T cell line JurkatInternational Immunopharmacology, 2001
- Selective Loss of Sphingosine 1-Phosphate Signaling with No Obvious Phenotypic Abnormality in Mice Lacking Its G Protein-coupled Receptor, LPB3/EDG-3Journal of Biological Chemistry, 2001
- Ceramide Enables Fas to Cap and KillJournal of Biological Chemistry, 2001
- FTV 720A mediates reduction of lymphocyte counts in human renal allograft recipients by an apoptosis-independent mechanismTransplant International, 2000
- HUMAN PHARMACOKINETICS OF FTY 720Transplantation, 1999
- HUMAN SAFETY AND PHARMACOLOGY OF FTY 720Transplantation, 1999